(12439798), J. B., (8827331), Z. L., (160944), D. H., (226957), L. L., (429860), J. H., (91924), X. W., . . . (203681), Y. Z. (2025). Table 1_Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study.docx.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(12439798), Junfeng Bu, Zihan Li (8827331), Die Hu (160944), Ling Lan (226957), Jiwei Huang (429860), Xin Wang (91924), Qiu Li (2127361), Jin Zhou (90734), و Yong Zeng (203681). Table 1_Enhanced Efficacy of Immune Checkpoint Inhibitors Combined Locoregional Therapy and Tyrosine Kinase Inhibitors in the Treatment of Unresectable Hepatocellular Carcinoma: A Single - Center Retrospective Study.docx. 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(12439798), Junfeng Bu, et al. Table 1_Enhanced Efficacy of Immune Checkpoint Inhibitors Combined Locoregional Therapy and Tyrosine Kinase Inhibitors in the Treatment of Unresectable Hepatocellular Carcinoma: A Single - Center Retrospective Study.docx. 2025.